<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37486805</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-4935</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>31</Day></PubDate></JournalIssue><Title>Bioscience reports</Title><ISOAbbreviation>Biosci Rep</ISOAbbreviation></Journal><ArticleTitle>The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">BSR20230595</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1042/BSR20230595</ELocationID><Abstract><AbstractText>SARS-CoV-2 (COVID-19) exerts profound changes in the kynurenine (Kyn) pathway (KP) of tryptophan (Trp) metabolism that may underpin its pathophysiology. The KP is the main source of the vital cellular effector NAD+ and intermediate metabolites that modulate immune and neuronal functions. Trp metabolism is the top pathway influenced by COVID-19. Sixteen studies established virus-induced activation of the KP mediated mainly by induction of indoleamine 2,3-dioxygenase (IDO1) in most affected tissues and of IDO2 in lung by the increased release of proinflammatory cytokines but could additionally involve increased flux of plasma free Trp and induction of Trp 2,3-dioxygenase (TDO) by cortisol. The major Kyn metabolite targeted by COVID-19 is kynurenic acid (KA), the Kyn metabolite with the greatest affinity for the aryl hydrocarbon receptor (AhR), which is also activated by COVID-19. AhR activation initiates two important series of events: a vicious circle involving IDO1 induction, KA accumulation and further AhR activation, and activation of poly (ADP-ribose) polymerase (PARP) leading to NAD+ depletion and cell death. The virus further deprives the host of NAD+ by inhibiting its main biosynthetic pathway from quinolinic acid, while simultaneously acquiring NAD+ by promoting its synthesis from nicotinamide in the salvage pathway. Additionally, the protective effects of sirtuin 1 are minimised by the PARP activation. KP dysfunction may also underpin the mood and neurological disorders acutely and during 'long COVID'. More studies of potential effects of vaccination therapy on the KP are required and exploration of therapeutic strategies involving modulation of the KP changes are proposed.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Badawy</LastName><ForeName>Abdulla Abu-Bakr</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-8743-2804</Identifier><AffiliationInfo><Affiliation>Formerly School of Health Sciences, Cardiff Metropolitan University, Western Avenue, Cardiff CF5 2YB, Wales, U.K.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biosci Rep</MedlineTA><NlmUniqueID>8102797</NlmUniqueID><ISSNLinking>0144-8463</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>343-65-7</RegistryNumber><NameOfSubstance UI="D007737">Kynurenine</NameOfSubstance></Chemical><Chemical><RegistryNumber>8DUH1N11BX</RegistryNumber><NameOfSubstance UI="D014364">Tryptophan</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067856">Poly(ADP-ribose) Polymerase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0U46U6E8UK</RegistryNumber><NameOfSubstance UI="D009243">NAD</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007737" MajorTopicYN="Y">Kynurenine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014364" MajorTopicYN="N">Tryptophan</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067856" MajorTopicYN="N">Poly(ADP-ribose) Polymerase Inhibitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009243" MajorTopicYN="N">NAD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007167" MajorTopicYN="N">Immunotherapy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3-dioxygenase</Keyword><Keyword MajorTopicYN="N">Aryl hydrocarbon receptor</Keyword><Keyword MajorTopicYN="N">Indoleamine 2</Keyword><Keyword MajorTopicYN="N">Kynurenic acid</Keyword><Keyword MajorTopicYN="N">Poly (ADP-ribose) polymerase</Keyword><Keyword MajorTopicYN="N">Proinflammatory cytokines</Keyword><Keyword MajorTopicYN="N">Tryptophan 2</Keyword></KeywordList><CoiStatement>The author declares that there are no competing interests associated with the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>19</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37486805</ArticleId><ArticleId IdType="pmc">PMC10407158</ArticleId><ArticleId IdType="doi">10.1042/BSR20230595</ArticleId><ArticleId IdType="pii">233311</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bender D.A. (1983) Biochemistry of tryptophan in health and disease. Molec. Aspects Med. 6, 1&#x2013;97 10.1016/0098-2997(83)90005-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0098-2997(83)90005-5</ArticleId><ArticleId IdType="pubmed">6371429</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A.-B. (2022) Tryptophan metabolism and disposition in cancer biology and immunotherapy. Biosci. Rep. 42, 1&#x2013;27, BSR20221682 10.1042/BSR20221682</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20221682</ArticleId><ArticleId IdType="pmc">PMC9653095</ArticleId><ArticleId IdType="pubmed">36286592</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A.-B. (2017) Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects. Int. J. Tryptophan Res. 10, 1&#x2013;20 10.1177/1178646917691938</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1178646917691938</ArticleId><ArticleId IdType="pmc">PMC5398323</ArticleId><ArticleId IdType="pubmed">28469468</ArticleId></ArticleIdList></Reference><Reference><Citation>Inada J., Okuno E., Kimura M. and Kido R. (1984) Intracellular localization and characterization of 3-hydroxykynureninase in human liver. Int. J. Biochem. 16, 623&#x2013;628 10.1016/0020-711X(84)90031-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0020-711X(84)90031-4</ArticleId><ArticleId IdType="pubmed">6468727</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A.-B. and Dougherty D.M. (2016) Assessment of the human kynurenine pathway: comparisons and clinical implications of ethnic and gender differences in plasma tryptophan, kynurenine metabolites, and enzyme expressions at baseline and after acute tryptophan loading and depletion. Int. J. Tryptophan Res. 9, 31&#x2013;49 10.4137/IJTR.S38189</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/IJTR.S38189</ArticleId><ArticleId IdType="pmc">PMC4981220</ArticleId><ArticleId IdType="pubmed">27547036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda M., Tsuji H., Nakamura S., Ichiyama A., Nishizuka Y. and Hayaishi O. (1965) Studies on the biosynthesis of nicotinamide adenine dinucleotide II. A role of picolinic acid carboxylase in the biosynthesis of nicotinamide adenine dinucleotide from tryptophan in mammals. J. Biol. Chem. 240, 1395&#x2013;1401 10.1016/S0021-9258(18)97589-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)97589-7</ArticleId><ArticleId IdType="pubmed">14284754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai M., Funakoshi H., Takahashi H., Hayakawa T., Mizuno S., Matsumoto K.et al. . (2009) Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behaviour in mice. Mol. Brain 2, 8 10.1186/1756-6606-2-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-2-8</ArticleId><ArticleId IdType="pmc">PMC2673217</ArticleId><ArticleId IdType="pubmed">19323847</ArticleId></ArticleIdList></Reference><Reference><Citation>Terakata M., Fukuwatari T., Kadota E., Sano M., Kanai M., Nakamura T.et al. . (2013) The niacin required for optimum growth can be synthesized from L-tryptophan in growing mice lacking tryptophan 2,3-dioxygenase. J. Nutr. 143, 1046&#x2013;1051 10.3945/jn.113.176875</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/jn.113.176875</ArticleId><ArticleId IdType="pubmed">23700344</ArticleId></ArticleIdList></Reference><Reference><Citation>Too L.K., Li K.M., Suarna C., Maghzal G.J., Stocker R., McGregor I.S.et al. . (2016) Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function. Behav. Brain Res. 312, 102&#x2013;117 10.1016/j.bbr.2016.06.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2016.06.018</ArticleId><ArticleId IdType="pubmed">27316339</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A.-B. and Guillemin G.J. (2019) The plasma [kynurenine]/[tryptophan] ratio and indoleamine 2,3-dioxygenase: time for appraisal. Int. J. Tryptophan Res. 12, 1&#x2013;10 10.1177/1178646919868978</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1178646919868978</ArticleId><ArticleId IdType="pmc">PMC6710706</ArticleId><ArticleId IdType="pubmed">31488951</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A.-B. (2017) Kynurenine pathway and human systems. Exp. Gerontol. 129, 110770 10.1016/j.exger.2019.110770</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2019.110770</ArticleId><ArticleId IdType="pubmed">31704347</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A.-B. and Bano S. (2016) Tryptophan metabolism in rat liver after administration of tryptophan, kynurenine metabolites and kynureninase inhibitors. Int. J. Tryptophan Res. 9, 51&#x2013;65 10.4137/IJTR.S38190</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/IJTR.S38190</ArticleId><ArticleId IdType="pmc">PMC4982523</ArticleId><ArticleId IdType="pubmed">27547037</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami Y. and Saito K. (2013) Species and cell types difference in tryptophan metabolism. Int. J. Tryptophan Res. 6, 47&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3729336</ArticleId><ArticleId IdType="pubmed">23922502</ArticleId></ArticleIdList></Reference><Reference><Citation>Belladonna M.L., Grohmann U., Guidetti P., Volpi C., Bianchi R., Fioretti M.C.et al. . (2006) Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO1. J. Immunol. 177, 130&#x2013;137 10.4049/jimmunol.177.1.130</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.1.130</ArticleId><ArticleId IdType="pubmed">16785507</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffett J.R., Arun P., Puthillathu N., Vengilote R., Ives J.A., Badawy A.A.-B.et al. . (2020) Quinolinate as a marker for kynurenine metabolite formation and the unresolved question of NAD+ synthesis during inflammation and infection. Front. Immunol. 11, 31 10.3389/fimmu.2020.00031</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00031</ArticleId><ArticleId IdType="pmc">PMC7047773</ArticleId><ArticleId IdType="pubmed">32153556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario R.G., Baratte S., Speciale C. and Salvati P. (1996) Kynurenine enzymatic pathway in human monocytes-macrophages. Adv. Exp. Med. Biol. 398, 167&#x2013;170 10.1007/978-1-4613-0381-7_27</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4613-0381-7_27</ArticleId><ArticleId IdType="pubmed">8906261</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito K., Seishima M., Noma A., Markey S.P. and Heyes M.P. (1996) Cytokine and drug modulation of kynurenine pathway metabolism by blood mononuclear cells. Adv. Exp. Med. Biol. 398, 161&#x2013;165 10.1007/978-1-4613-0381-7_26</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4613-0381-7_26</ArticleId><ArticleId IdType="pubmed">8906260</ArticleId></ArticleIdList></Reference><Reference><Citation>Zunszain P.A., Anacker C., Cattaneo A., Choudhury S., Musaelyan K., Myint M.et al. . (2012) Interleukin-1&#x3b2;: A new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacol 37, 939, 10.1038/npp.2011.277</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2011.277</ArticleId><ArticleId IdType="pmc">PMC3280640</ArticleId><ArticleId IdType="pubmed">22071871</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones S.P., Franco N.F., Varney B., Sundaram G., Brown D.A., de Bie J.et al. . (2015) Expression of the kynurenine pathway in human peripheral blood mononuclear cells: implications for inflammatory and neurodegenerative disease. PLoS ONE 10, e0131389 10.1371/journal.pone.0131389</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0131389</ArticleId><ArticleId IdType="pmc">PMC4482723</ArticleId><ArticleId IdType="pubmed">26114426</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirthgen E., Hoeflich A., Rebl A. and G&#xfc;nther J. (2018) Kynurenic acid: the Janus-faced role of an immunomodulatory tryptophan metabolite and its link to pathological conditions. Front. Immunol. 8, 1957 10.3389/fimmu.2017.01957</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01957</ArticleId><ArticleId IdType="pmc">PMC5770815</ArticleId><ArticleId IdType="pubmed">29379504</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A.-B. (2018) Kynurenic and quinolinic acids: the main players of the kynurenine pathway and opponents in inflammatory disease. Med. Hypotheses 118, 129&#x2013;138 10.1016/j.mehy.2018.06.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2018.06.021</ArticleId><ArticleId IdType="pubmed">30037600</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A.-B., Namboodiri A.M. and Moffett J.R. (2016) The end of the road for the tryptophan depletion concept in pregnancy and infection. Clin. Sci. 130, 1327&#x2013;1333 10.1042/CS20160153</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20160153</ArticleId><ArticleId IdType="pmc">PMC4926258</ArticleId><ArticleId IdType="pubmed">27358028</ArticleId></ArticleIdList></Reference><Reference><Citation>Terness P., Bauer T.M., Rose L., Dufter C., Watzlik A., Simon H.et al. . (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase Expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196, 447&#x2013;457 10.1084/jem.20020052</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20020052</ArticleId><ArticleId IdType="pmc">PMC2196057</ArticleId><ArticleId IdType="pubmed">12186837</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallarino F., Grohmann U., Vacca C., Bianchi R., Orabona C., Spreca A.et al. . (2020) T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9, 1069&#x2013;1077 10.1038/sj.cdd.4401073</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401073</ArticleId><ArticleId IdType="pubmed">12232795</ArticleId></ArticleIdList></Reference><Reference><Citation>Julliard W., Fechner J.H. and Mezrich J.D. (2014) The aryl hydrocarbon receptor meets immunology: friend or foe? A little of both Front. Immunol. 5, 1&#x2013;6Article 458 10.3389/fimmu.2014.00458</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00458</ArticleId><ArticleId IdType="pmc">PMC4183121</ArticleId><ArticleId IdType="pubmed">25324842</ArticleId></ArticleIdList></Reference><Reference><Citation>DiNatale B.C., Murray I.A., Schroeder J.C., Flaveny C.A., Lahoti T.S., Laurenzana M.et al. . (2010) Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol. Sci. 115, 89&#x2013;97 10.1093/toxsci/kfq024</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfq024</ArticleId><ArticleId IdType="pmc">PMC2855350</ArticleId><ArticleId IdType="pubmed">20106948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbard T.D., Murray I.A., Bisson W.H., Lahoti T.S., Gowda K., Amin S.G.et al. . (2015) Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci. Rep. 5, 12689 10.1038/srep12689</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep12689</ArticleId><ArticleId IdType="pmc">PMC4522678</ArticleId><ArticleId IdType="pubmed">26235394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P., Lee J.-H. and Lee J. (2021) Diverse roles of microbial indole compounds in eukaryotic systems. Biol. Rev. Camb. Philos. Soc. 96, 2522&#x2013;2545 10.1111/brv.12765</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/brv.12765</ArticleId><ArticleId IdType="pmc">PMC9290978</ArticleId><ArticleId IdType="pubmed">34137156</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadek A., Somarribas Patterson L.F., &#xd6;zt&#xfc;rk S., Mohapatra S.R., Panitz V., Secker P.F.et al. . (2020) IL4I1 is a metabolic immune checkpoint that activates the AhR and promotes tumor progression. Cell 182, 1252&#x2013;1270 e20-e34</Citation><ArticleIdList><ArticleId IdType="pubmed">32818467</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;berg M., Bergander L., H&#xe4;kansson H., Rannug U. and Rannug A. (2005) Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity. Toxicol. Sci. 85, 935&#x2013;943 10.1093/toxsci/kfi154</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfi154</ArticleId><ArticleId IdType="pubmed">15788723</ArticleId></ArticleIdList></Reference><Reference><Citation>Smirnova A., Wincent E., Vikstr&#xf6;m Bergander L., Alsberg T., Bergman J., Rannug A.et al. . (2016) Evidence for new light-independent pathways for generation of the endogenous aryl hydrocarbon receptor agonist FICZ. Chem. Res. Toxicol. 29, 75&#x2013;86 10.1021/acs.chemrestox.5b00416</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrestox.5b00416</ArticleId><ArticleId IdType="pubmed">26686552</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel C.F.A., Goth S.R., Dong B., Pessah I.N. and Matsumura F. (2008) Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem. Biophys. Res. Commun. 375, 331&#x2013;335 10.1016/j.bbrc.2008.07.156</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2008.07.156</ArticleId><ArticleId IdType="pmc">PMC2583959</ArticleId><ArticleId IdType="pubmed">18694728</ArticleId></ArticleIdList></Reference><Reference><Citation>Litzenburger U.M., Opitz C.A., Sahm F., Rauschenbach K.J., Trump S., Winter M.et al. . (2014) Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR. Oncotarget 5, 1038&#x2013;1051 10.18632/oncotarget.1637</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.1637</ArticleId><ArticleId IdType="pmc">PMC4011581</ArticleId><ArticleId IdType="pubmed">24657910</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A.-B. (2020) Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide. Biosci. Rep. 40, BSR20202856 10.1042/BSR20202856</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20202856</ArticleId><ArticleId IdType="pmc">PMC7601349</ArticleId><ArticleId IdType="pubmed">33063092</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y., Uchi H., Hashimoto-Hachiya A. and Furue M. (2018) Tryptophan photoproduct FICZ upregulates IL1A, IL1B, and IL6 expression via oxidative stress in keratinocytes. Hindawi Oxid. Med. Cell Longev. 218, 1&#x2013;10Article ID 9298052 10.1155/2018/9298052</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/9298052</ArticleId><ArticleId IdType="pmc">PMC6286782</ArticleId><ArticleId IdType="pubmed">30595799</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E.et al. . (2008) Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65&#x2013;71 10.1038/nature06880</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06880</ArticleId><ArticleId IdType="pubmed">18362915</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renaud J.-C.et al. . (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106&#x2013;109 10.1038/nature06881</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06881</ArticleId><ArticleId IdType="pubmed">18362914</ArticleId></ArticleIdList></Reference><Reference><Citation>Dere E., Boverhof D.R., Burgoon L.D. and Zacharewski T.R. (2006) In vivo-in vitro toxicogenomic comparison of TCDD-elicited gene expression in Hepa1c1c7 mouse hepatoma cells and C57BL/6 hepatic tissue. BMC Genomics 7, 80 10.1186/1471-2164-7-80</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-7-80</ArticleId><ArticleId IdType="pmc">PMC1513214</ArticleId><ArticleId IdType="pubmed">16611356</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen M.S. (2020) Interplay between compartmentalized NAD+ synthesis an consumption: a focus on the PARP family. Genes Develop 34, 254&#x2013;262 10.1101/gad.335109.119</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.335109.119</ArticleId><ArticleId IdType="pmc">PMC7050480</ArticleId><ArticleId IdType="pubmed">32029457</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha H.C. and Snyder S.H. (1999) Poly (ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. U.S.A. 96, 13978&#x2013;13982 10.1073/pnas.96.24.13978</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.24.13978</ArticleId><ArticleId IdType="pmc">PMC24176</ArticleId><ArticleId IdType="pubmed">10570184</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales J.C., Li L., Fattah F.J., Dong Y., Bey E.A., Patel M.et al. . (2014) Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. Crit. Rev. Eukaryot. Gene Expr. 24, 15&#x2013;28 10.1615/CritRevEukaryotGeneExpr.2013006875</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/CritRevEukaryotGeneExpr.2013006875</ArticleId><ArticleId IdType="pmc">PMC4806654</ArticleId><ArticleId IdType="pubmed">24579667</ArticleId></ArticleIdList></Reference><Reference><Citation>Angrish M.M., Dominici C.Y. and Zacharewski T.R. (2013) TCDD-elicited effects on liver, serum, and adipose lipid composition in C57BL/6 mice. Toxicol. Sci. 131, 108&#x2013;115 10.1093/toxsci/kfs277</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfs277</ArticleId><ArticleId IdType="pmc">PMC3537129</ArticleId><ArticleId IdType="pubmed">22977169</ArticleId></ArticleIdList></Reference><Reference><Citation>Girer N.G., Tomlinson C.R. and Elferink C.J. (2021) The aryl hydrocarbon receptor in energy balance: the road from dioxin-induced wasting syndrome to combating obesity with AhR ligands. Int. J. Molec. Sci. 22, 49 10.3390/ijms22010049</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010049</ArticleId><ArticleId IdType="pmc">PMC7793057</ArticleId><ArticleId IdType="pubmed">33374508</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y.et al. . (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497&#x2013;506 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhang C., Huang F., Yang Y., Wang F. and Yuan J. (2020) Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury. Nat. Sci. Rev. 7, 1003&#x2013;1011 10.1093/nsr/nwaa037</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa037</ArticleId><ArticleId IdType="pmc">PMC7107806</ArticleId><ArticleId IdType="pubmed">34676126</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C., Wong P., Klein J., Castro T.B.R., Silva J., Sundaram M.et al. . (2020) Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 363&#x2013;469 10.1038/s41586-020-2588-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing A.G., Lorenc A., del Molino del Barrio R., Das A., Fish M., Monin L.et al. . (2020) A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat. Med. 26, 1623&#x2013;1635 10.1038/s41591-020-1038-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1038-6</ArticleId><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker J.R., Mahdi M., Nicolau D.V. Jr, Ramakrishnan S., Barnes P.J., Simpson J.L.et al. . (2022) Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis. Lancet Respir. Med. 10, 545&#x2013;556 10.1016/S2213-2600(22)00002-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00002-9</ArticleId><ArticleId IdType="pmc">PMC8989397</ArticleId><ArticleId IdType="pubmed">35397798</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J., Wang S., Xia H., Shi D., Chen Y., Sheng S.et al. . (2021) Cytokine signature associated With disease severity in COVID-19. Front. Immunol. 12, 681516 10.3389/fimmu.2021.681516</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.681516</ArticleId><ArticleId IdType="pmc">PMC8418386</ArticleId><ArticleId IdType="pubmed">34489933</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawler N.G., Gray N., Kimhofer T., Boughton B., Gay M., Yang R.et al. . (2021) Systemic perturbations in amine and kynurenine metabolism associated with acute SARS-CoV-2 infection and inflammatory cytokine responses. J. Proteome Res. 20, 2796&#x2013;2811 10.1021/acs.jproteome.1c00052</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00052</ArticleId><ArticleId IdType="pubmed">33724837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J., Yatim N., Barnabei L., Corneau A., Boussier J., Smith N.et al. . (2020) I Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718&#x2013;724 10.1126/science.abc6027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao N., Nie M., Pang H., Wang B., Hu J., Meng X.et al. . (2021) Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications. Nat. Commun. 12, 1618 10.1038/s41467-021-21907-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21907-9</ArticleId><ArticleId IdType="pmc">PMC7955129</ArticleId><ArticleId IdType="pubmed">33712622</ArticleId></ArticleIdList></Reference><Reference><Citation>Reizine F., Lesouhaitier M., Gregoire M., Pinceaux K., Gacouin A., Maamar A.et al. . (2021) SARS-CoV 2-induced ARDS associates with MDSC expansion, lymphocyte dysfunction, and arginine shortage. J. Clin. Immunol. 41, 515&#x2013;525 10.1007/s10875-020-00920-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-020-00920-5</ArticleId><ArticleId IdType="pmc">PMC7775842</ArticleId><ArticleId IdType="pubmed">33387156</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozaki Y., Edelstein M.P. and Duch D.S. (1987) The actions of interferons and antiinflammatory agents on induction of indoleamine 2,3-dioxygenase in human peripheral blood monocytes. Biochem. Biophys. Res. Commun. 144, 1147&#x2013;1153 10.1016/0006-291X(87)91431-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(87)91431-8</ArticleId><ArticleId IdType="pubmed">3107562</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassanain H.H., Chon S.Y. and Gupta S.L. (1993) Differential regulation of human indoleamine 2,3 dioxygenase gene expression by interferons-&#x3b3; and -&#x3b1;: analysis of the regulatory region of the gene and identification of an interferon-7-inducible DNA-binding factor. J. Biol. Chem. 268, 5077&#x2013;5084 10.1016/S0021-9258(18)53504-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)53504-3</ArticleId><ArticleId IdType="pubmed">8444884</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams O., Besken K., Oberd&#xf6;rfer C., MacKenzie C.R., Takikawa O. and D&#xe4;ubener W. (2004) Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J. Virol. 78, 2632&#x2013;2636 10.1128/JVI.78.5.2632-2636.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.5.2632-2636.2004</ArticleId><ArticleId IdType="pmc">PMC369218</ArticleId><ArticleId IdType="pubmed">14963171</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKenzie C.R., Gonz&#xe1;lez R.G., Kniep E. and D&#xe4;ubener W. (1999) 0 Cytokine mediated regulation of interferon-gamma-induced IDO activation. Adv. Exp. Med. Biol. 467, 533&#x2013;539 10.1007/978-1-4615-4709-9_66</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4615-4709-9_66</ArticleId><ArticleId IdType="pubmed">10721097</ArticleId></ArticleIdList></Reference><Reference><Citation>Banzola I., Mengus C., Wyler S., Hudolin T., Manzella G., Chiarugi A.et al. . (2018) Expression of indoleamine 2,3-dioxygenase induced by IFN-&#x3b3; and TNF-&#x3b1; as potential biomarker of prostate cancer progression. Front. Immunol. 29, 1051 10.3389/fimmu.2018.01051</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01051</ArticleId><ArticleId IdType="pmc">PMC5986916</ArticleId><ArticleId IdType="pubmed">29896191</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberati-Giani D., Ricciardi-Castagnoli P., Kohler C. and Cesura A.M. (1996) Regulation of the kynurenine pathway by IFN-&#x3b3; in murine cloned macrophages and microglial cells. Adv. Exp. Med. Biol. 398, 171&#x2013;175 10.1007/978-1-4613-0381-7_28</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4613-0381-7_28</ArticleId><ArticleId IdType="pubmed">8906262</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B., Yi X., Sun Y., Bi X., Du J., Zhang C.et al. . (2020) Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182, 59&#x2013;72 10.1016/j.cell.2020.05.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T., Stefanoni D., Reisz J.A., Nemkov T., Bertolone L., Francis R.O.et al. . (2020) COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. J. Clin. Invest. Insight 5, e140327 10.1172/jci.insight.140327</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimhofer T., Lodge S., Whiley L., Gray N., Loo R.L., Lawler N.G.et al. . (2020) Integrative modeling of quantitative plasma lipoprotein, metabolic, and amino acid data reveals a multiorgan pathological signature of SARS-CoV-2 infection. J. Proteome Res. 19, 4442&#x2013;4454 10.1021/acs.jproteome.0c00519</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00519</ArticleId><ArticleId IdType="pubmed">32806897</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson J., Gostner J.M., Nilsson S., Andersson L.-M., Fuchs D. and Gisslen M. (2020) Serum neopterin levels in relation to mild and severe COVID-19. BMC Infect. Dis. 20, 942 10.1186/s12879-020-05671-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05671-7</ArticleId><ArticleId IdType="pmc">PMC7726600</ArticleId><ArticleId IdType="pubmed">33302893</ArticleId></ArticleIdList></Reference><Reference><Citation>Lionetto L., Ulivieri M., Capi M., De Bernardini D., Fazio F., Petrucca A.et al. . (2021) Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: an observational cohort study. Biochim. Biophys. Acta Molec. Basis Dis. 1867, 166042 10.1016/j.bbadis.2020.166042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2020.166042</ArticleId><ArticleId IdType="pmc">PMC7834629</ArticleId><ArticleId IdType="pubmed">33338598</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangge H., Herrmann M., Meinitzer A., Pailer S., Curcic P., Sloup Z.et al. . (2021) Increased Kynurenine Indicates a Fatal Course of COVID-19. Antioxidants 10, 1960 10.3390/antiox10121960</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10121960</ArticleId><ArticleId IdType="pmc">PMC8750518</ArticleId><ArticleId IdType="pubmed">34943063</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed;n-Corral J., Rodr&#xed;guez-Morat&#xf3; J., Gomez-Gomez A., Pascual-Guardia S., Mu&#xf1;oz-Berm&#xfa;dez R., Salazar-Degracia A.et al. . (2021) Metabolic signatures associated with severity in hospitalized COVID-19 patients. Int. J. Molec. Sci. 22, 4797 10.3390/ijms22094794</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094794</ArticleId><ArticleId IdType="pmc">PMC8124482</ArticleId><ArticleId IdType="pubmed">33946479</ArticleId></ArticleIdList></Reference><Reference><Citation>Alb&#xf3;niga O.E., Jim&#xe9;nez D., S&#xe1;nchez-Conde M., Vizcarra P., Ron R., Herrera S.et al. . (2022) Metabolic snapshot of plasma samples reveals new pathways implicated in SARS-CoV-2 pathogenesis. J. Proteome Res. 21, 623&#x2013;634 10.1021/acs.jproteome.1c00786</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00786</ArticleId><ArticleId IdType="pubmed">35133846</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I., Muelas M.W., Taylor J.M., Davison A.S., Xu Y., Grixti J.M.et al. . (2022) Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome. Metabolomics 18, 6 10.1007/s11306-021-01859-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-021-01859-3</ArticleId><ArticleId IdType="pmc">PMC8686810</ArticleId><ArticleId IdType="pubmed">34928464</ArticleId></ArticleIdList></Reference><Reference><Citation>Trovato F.M., Mujib S., Jerome E., Cavazzo A., Morgan P., Smith J.et al. . (2022) Immunometabolic analysis shows a distinct cyto-metabotype in Covid-19 compared to sepsis from other causes. Heliyon 8, e09733 10.1016/j.heliyon.2022.e09733</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2022.e09733</ArticleId><ArticleId IdType="pmc">PMC9225950</ArticleId><ArticleId IdType="pubmed">35774516</ArticleId></ArticleIdList></Reference><Reference><Citation>Cihan M., Do&#x11f;an &#xd6;., Serdar C.C., Yildir&#x131;m A.A., Kurt C. and Serdar M.A. (2022) Kynurenine pathway in coronavirus disease (COVID-19): potential role in prognosis. J. Clin. Lab. Anal. 36, 1.e24257&#x2013;10.e24257 10.1002/jcla.24257</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.24257</ArticleId><ArticleId IdType="pmc">PMC8906035</ArticleId><ArticleId IdType="pubmed">35092710</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansone L., Briviba M., Silamikelis I., Terentjeva A., Perkons I., Birzniece L.et al. . (2021) Amino acid metabolism is significantly altered at the time of admission in hospital for severe COVID-19 patients: Findings from longitudinal targeted metabolomics analysis. Microbiol. Spectrum.asm.org. 9, e00338&#x2013;e00421 10.1128/spectrum.00338-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.00338-21</ArticleId><ArticleId IdType="pmc">PMC8653833</ArticleId><ArticleId IdType="pubmed">34878333</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Schurink B., Roos E., Nossent E., Duitman J.W., Pj Vlaar A.et al. . (2022) Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19. J. Pathol. 256, 256&#x2013;261 10.1002/path.5842</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5842</ArticleId><ArticleId IdType="pmc">PMC8897979</ArticleId><ArticleId IdType="pubmed">34859884</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif-Askari N.S., Soares N.C., Mohamed H.J., Sharif-Askari F., Alsayed H.A., Al-Hroub H.et al. . (2022) Saliva metabolomic profile of COVID-19 patients associates with disease severity. Metabolomics 18, 81 10.1007/s11306-022-01936-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-022-01936-1</ArticleId><ArticleId IdType="pmc">PMC9589589</ArticleId><ArticleId IdType="pubmed">36271948</ArticleId></ArticleIdList></Reference><Reference><Citation>Panesar N.S. (2008) What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients? Med. Hypotheses 71, 298&#x2013;301 10.1016/j.mehy.2008.03.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2008.03.019</ArticleId><ArticleId IdType="pmc">PMC7131352</ArticleId><ArticleId IdType="pubmed">18448259</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A.-B. and Guillemin G. (2019) The plasma [kynurenine]/[tryptophan] ratio and indoleamine 2,3 dioxygenase: time for appraisal. Int. J. Tryptophan Res. 12, 1&#x2013;10 10.1177/1178646919868978</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1178646919868978</ArticleId><ArticleId IdType="pmc">PMC6710706</ArticleId><ArticleId IdType="pubmed">31488951</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin S., Li W., Shi X., Wu Y., Wang C., Shen J.et al. . (2021) 3044 Cases reveal important prognosis signatures of COVID-19 patients. Computat. Struct. Biotechnol. J. 19, 1163&#x2013;1175 10.1016/j.csbj.2021.01.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2021.01.042</ArticleId><ArticleId IdType="pmc">PMC7870437</ArticleId><ArticleId IdType="pubmed">33584997</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Li M., Zheng S., Li M., Zhang M., Sun M.et al. . (2020) Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19. Biomark. Med. 14, 827&#x2013;837 10.2217/bmm-2020-0254</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2020-0254</ArticleId><ArticleId IdType="pmc">PMC7273900</ArticleId><ArticleId IdType="pubmed">32490680</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheir M., Saleem F., Wang C., Mann A. and Chua J. (2021) Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19. PLoS ONE 16, e0248358 10.1371/journal.pone.0248358</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0248358</ArticleId><ArticleId IdType="pmc">PMC7963065</ArticleId><ArticleId IdType="pubmed">33725003</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbani G. and Ahn S.N. (2021) Roles of human serum albumin in prediction, diagnoses and treatment of COVID-19. Int. J. Biol. Macromol. 193, 948&#x2013;955 10.1016/j.ijbiomac.2021.10.095</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2021.10.095</ArticleId><ArticleId IdType="pmc">PMC8520831</ArticleId><ArticleId IdType="pubmed">34673106</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A.-B. (2020) Kynurenine pathway and human systems. Exp. Gerontol. 129, 110770 10.1016/j.exger.2019.110770</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2019.110770</ArticleId><ArticleId IdType="pubmed">31704347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Shu T., Yang X., Song J.-X., Zhang M., Yao C.et al. . (2020) Plasma metabolomic and lipidomic alterations associated with COVID-19. Nat. Sci. Rev. 7, 1157&#x2013;1168 10.1093/nsr/nwaa086</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa086</ArticleId><ArticleId IdType="pmc">PMC7197563</ArticleId><ArticleId IdType="pubmed">34676128</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis E., Timo S., Amede E., Vanella V.V., Puricelli C., Cappellano G.et al. . (2020) Large-scale plasma analysis revealed new mechanisms and molecules associated with the host response to SARS-CoV-2. Int. J. Molec. Sci. 21, 8623 10.3390/ijms21228623</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228623</ArticleId><ArticleId IdType="pmc">PMC7696386</ArticleId><ArticleId IdType="pubmed">33207699</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen M., Bourredjem A., Piroth L., Bouhemad B., Jalil A., Pallot G.et al. . (2021) High plasma concentration of non-esterified polyunsaturated fatty acids is a specific feature of severe COVID-19 pneumonia. Scient. Rep. 11, 10824 10.1038/s41598-021-90362-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90362-9</ArticleId><ArticleId IdType="pmc">PMC8144366</ArticleId><ArticleId IdType="pubmed">34031519</ArticleId></ArticleIdList></Reference><Reference><Citation>Triana-Baltzer G., Timmers M., De Boer P., Schoene M., Furey M., Bleys C.et al. . (2022) Profiling classical neuropsychiatric biomarkers across biological fluids and following continuous lumbar puncture: A guide to sample type and time. Comprehen. Psychoneuroendocrinol. 10, 100116 10.1016/j.cpnec.2022.100116</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpnec.2022.100116</ArticleId><ArticleId IdType="pmc">PMC9231640</ArticleId><ArticleId IdType="pubmed">35774109</ArticleId></ArticleIdList></Reference><Reference><Citation>Vining R.F., McGinley R.A. and Symons R.G. (1983) Hormones in saliva: mode of entry and consequent implications for clinical interpretation. Clin. Chem. 29, 1752&#x2013;1756 10.1093/clinchem/29.10.1752</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/29.10.1752</ArticleId><ArticleId IdType="pubmed">6225566</ArticleId></ArticleIdList></Reference><Reference><Citation>Edmonds E.J., Bell R.W. Jr and Beetrstecher E. Jr (1957) Salivary tryptophan and its relationship to DMF. J. Dental Res. 36, 839&#x2013;842 10.1177/00220345570360060401</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00220345570360060401</ArticleId><ArticleId IdType="pubmed">13481218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapila R., Nagesh K.S., Iyengar A. and Divyalakshmi (2012) Diabetes and oral changes: The tryptophan metabolism link? J. Clin. Diagnostic Res. 6, 517&#x2013;520</Citation></Reference><Reference><Citation>Morita I., Kawamoto M. and Yoshida H. (1992) Difference in the concentration of tryptophan metabolites between maternal and umbilical foetal blood. J. Chromatogr. 576, 334&#x2013;339 10.1016/0378-4347(92)80208-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-4347(92)80208-8</ArticleId><ArticleId IdType="pubmed">1400722</ArticleId></ArticleIdList></Reference><Reference><Citation>Amiri-Dashatan N., Koushki M., Parsamanesh N. and Chiti H. (2022) Serum cortisol concentration and COVID-19 severity: a systematic review and meta-analysis. Invest. Med. 70, 766&#x2013;772 10.1136/jim-2021-001989</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-001989</ArticleId><ArticleId IdType="pubmed">35058334</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensterle M., Herman R., Jane&#x17e; A., Mahmeed W., Al-Rasadi K., Al-Alawi K.et al. . (2022) The Relationship between COVID-19 and hypothalamic-pituitary adrenal axis: a large spectrum from glucocorticoid insufficiency to excess-the CAPISCO International Expert Panel. Int. J. Mol. Sci. 23, 7326 10.3390/ijms23137326</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137326</ArticleId><ArticleId IdType="pmc">PMC9266848</ArticleId><ArticleId IdType="pubmed">35806331</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzahrani A.S., Mukhtar N., Aljomaiah A., Aljamei H., Bakhsh A., Alsudani N.et al. . (2021) The impact of COVID-19 viral infection on the hypothalamic-pituitary-adrenal axis. Endocr. Pract. 27, 83&#x2013;89 10.1016/j.eprac.2020.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2020.10.014</ArticleId><ArticleId IdType="pmc">PMC7837186</ArticleId><ArticleId IdType="pubmed">33554871</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan T., Khoo B., Mills E.G., Phylactou M., Patel B., Eng P.C.et al. . (2020) Association between high serum total cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol. 8, 659&#x2013;660 10.1016/S2213-8587(20)30216-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30216-3</ArticleId><ArticleId IdType="pmc">PMC7302794</ArticleId><ArticleId IdType="pubmed">32563278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota T., Hirota K., Sanno Y. and Tanaka T. (1985) Appearance of new hepatic glucocorticoid binding proteins under various stressful conditions: relation to endogenous glucocorticoid secretion. J. Biochem. (Tokyo) 97, 1371&#x2013;1376 10.1093/oxfordjournals.jbchem.a135190</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.jbchem.a135190</ArticleId><ArticleId IdType="pubmed">4030727</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota T., Hirotam K., Sanno Y. and Tanaka T. (1985) A new glucocorticoid receptor species: relation to induction of tryptophan dioxygenase by glucocorticoids. Endocrinology 117, 1788&#x2013;1795 10.1210/endo-117-5-1788</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endo-117-5-1788</ArticleId><ArticleId IdType="pubmed">2864234</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y.et al. . (2020) Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin. Infect. Dis. 71, 762&#x2013;768 10.1093/cid/ciaa248</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa248</ArticleId><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Panesar N.S., Lam C.W.K., Chan M.H.M., Wong C.K. and Sung J.J.Y. (2004) Lymphopenia and neutrophilia in SARS are related to the prevailing serum cortisol. Eur. J. Clin. Invest. 34, 382&#x2013;384 10.1111/j.1365-2362.2004.01347.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2004.01347.x</ArticleId><ArticleId IdType="pmc">PMC7163702</ArticleId><ArticleId IdType="pubmed">15147338</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoomikarimi M., Garmabi B., Alizadeh J., Kazemi E., Azari A., Mirmoeeni S.et al. . (2021) Advances in immunotherapy for COVID-19: A comprehensive review. Int. Immunopharmacol. 93, 107409 10.1016/j.intimp.2021.107409</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107409</ArticleId><ArticleId IdType="pmc">PMC7826020</ArticleId><ArticleId IdType="pubmed">33581501</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Ren L., Zhang L., Zhong J., Xiaop Y., Jia Z.et al. . (2020) Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe 27, 883&#x2013;890 10.1016/j.chom.2020.04.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.017</ArticleId><ArticleId IdType="pmc">PMC7196896</ArticleId><ArticleId IdType="pubmed">32407669</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardinassi L.G., Souza C.O.S., Sales-Campos H. and Fonseca S.G. (2020) Immune and metabolic signatures of COVID-19 revealed by transcriptomics data reuse. Front. Immunol. 11, 1636 10.3389/fimmu.2020.01636</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01636</ArticleId><ArticleId IdType="pmc">PMC7332781</ArticleId><ArticleId IdType="pubmed">32670298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridges J., Vladar E.K., Huang H. and Mason R.J. (2022) Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19. Thorax 77, 203&#x2013;209 10.1136/thoraxjnl-2021-217561</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217561</ArticleId><ArticleId IdType="pmc">PMC9273148</ArticleId><ArticleId IdType="pubmed">34404754</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohn M.K., Hall A., Sepiashvili L., Jung B., Steele S. and Adeli K. (2020) Pathophysiology of COVID-19: mechanisms underlying disease severity and progression. Physiol. Online 35, 288&#x2013;301 10.1152/physiol.00019.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiol.00019.2020</ArticleId><ArticleId IdType="pmc">PMC7426542</ArticleId><ArticleId IdType="pubmed">32783610</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A., Chauhan P., Saha B., Jafarzadeh S. and Nemati M. (2020) Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Life Sci. 257, 118102 10.1016/j.lfs.2020.118102</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118102</ArticleId><ArticleId IdType="pmc">PMC7367812</ArticleId><ArticleId IdType="pubmed">32687918</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordoni V., Tartaglia F., Sacchi A., Fimia G.M., Cimini E., Casetti R.et al. . (2021) The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients. Int. J. Infect. Dis. 105, 49&#x2013;53 10.1016/j.ijid.2021.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.02.019</ArticleId><ArticleId IdType="pmc">PMC7872850</ArticleId><ArticleId IdType="pubmed">33578018</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosales C. (2018) Neutrophil: a cell with many roles in inflammation and several cell types. Front Physiol. 9, 113 10.3389/fphys.2018.00113</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00113</ArticleId><ArticleId IdType="pmc">PMC5826082</ArticleId><ArticleId IdType="pubmed">29515456</ArticleId></ArticleIdList></Reference><Reference><Citation>Didangelos A. (2020) COVID-19 and inflammation: what about neutrophils? mSphere 5, e00367&#x2013;e00420 10.1128/mSphere.00367-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00367-20</ArticleId><ArticleId IdType="pmc">PMC7316488</ArticleId><ArticleId IdType="pubmed">32581077</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustamante S., Yau Y., Boys V., Chang J., Paramsothy S., Pudipeddi A.et al. . (2022) Tryptophan metabolism &#x2018;Hub&#x2019; gene expression associates with increased inflammation and severe disease outcomes in COVID-19 infection and inflammatory bowel disease. Int. J. Molec. Sci. 23, 14776 10.3390/ijms232314776</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232314776</ArticleId><ArticleId IdType="pmc">PMC9737535</ArticleId><ArticleId IdType="pubmed">36499104</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A. (2021) Olfactory nasal nitric oxide link in COVID-19: a marker of neurogenesis or risk factor for chronic rhinosinusitis? Am. J. Resp. Crit. Care Med. 11, 1345&#x2013;1347 10.1164/rccm.202107-1697LE</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202107-1697LE</ArticleId><ArticleId IdType="pmc">PMC8786068</ArticleId><ArticleId IdType="pubmed">34491873</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y., Kim D.J., Takahashi T., Broadhurst D., Yan H., Ma S.et al. . (2021) Kynurenic acid may underlie sex-specific immune responses to COVID-19. Sci. Signal. 14, eabf8483 10.1126/scisignal.abf8483</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.abf8483</ArticleId><ArticleId IdType="pmc">PMC8432948</ArticleId><ArticleId IdType="pubmed">34230210</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago-Mujika E., Heinrich K., George S., Capan C.D., Forton C., Madaj Z.et al. . (2022) Increased levels of circulating neurotoxic metabolites in patients with mild Covid19. bioRxiv Preprint 2022, 1&#x2013;30 10.1101/2022.06.22.497189</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.22.497189</ArticleId></ArticleIdList></Reference><Reference><Citation>Soria-Castro R., Meneses-Preza Y.G., Rodr&#xed;guez-L&#xf3;pez G.M., Romero-Ram&#xed;rez S., Sosa-Hern&#xe1;ndez V.A., Cervantes-D&#xed;az R.et al. . (2021) Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin. J. Leukoc. Biol. 110, 425&#x2013;431 10.1002/JLB.4HI0221-087R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4HI0221-087R</ArticleId><ArticleId IdType="pmc">PMC8242632</ArticleId><ArticleId IdType="pubmed">34057753</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Lv J., Liu J., Li M., Xie J., Lv Q.et al. . (2020) Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19. Cell Res. 30, 1078&#x2013;1087 10.1038/s41422-020-00435-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-00435-z</ArticleId><ArticleId IdType="pmc">PMC7646495</ArticleId><ArticleId IdType="pubmed">33159154</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovannoni F., Li Z., Garcia C.C. and Quintana F.J. (2020) A potential role for AhR in SARS-CoV-2 pathology. Res. Sq. Preprint 2022, 1&#x2013;30rs.3.rs-25639 10.20123/rs.3.rs-25639/v1.preprint</Citation><ArticleIdList><ArticleId IdType="doi">10.20123/rs.3.rs-25639/v1.preprint</ArticleId></ArticleIdList></Reference><Reference><Citation>Turski W.A., Wnorowski A., Turski G.N., Turski C. and Turski L. (2020) AhR and IDO1 in pathogenesis of Covid-19 and the &#x201c;Systemic AhR Activation Syndrome:&#x201d; a translational review and therapeutic perspectives. Restor. Neurol. Neurosci. 38, 343&#x2013;354 10.3233/RNN-201042</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/RNN-201042</ArticleId><ArticleId IdType="pmc">PMC7592680</ArticleId><ArticleId IdType="pubmed">32597823</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunewald M.E., Shaban M.G., Mackin S.R., Fehr A.R. and Perlman S. (2020) Murine coronavirus infection activates the aryl hydrocarbon receptor in an indoleamine 2,3-dioxygenase-independent manner, contributing to cytokine modulation and proviral TCDD-inducible-PARP expression. J. Virol. 94, e01743&#x2013;e01819 10.1128/JVI.01743-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01743-19</ArticleId><ArticleId IdType="pmc">PMC7000979</ArticleId><ArticleId IdType="pubmed">31694960</ArticleId></ArticleIdList></Reference><Reference><Citation>Heer C.D., Sanderson D.J., Voth L.S., Alhammad Y.M.O., Schmidt M.S., Trammell S.A.J.et al. . (2020) Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity. J. Biol. Chem. 295, 17986&#x2013;17996 10.1074/jbc.RA120.015138</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.015138</ArticleId><ArticleId IdType="pmc">PMC7834058</ArticleId><ArticleId IdType="pubmed">33051211</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D., Nilsson-Payant B.E., Liu W.-C., Uhl S., Hoagland D., M&#xf8;ller R.et al. . (2020) SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems. Cell 181, 1036&#x2013;1045 10.1016/j.cell.2020.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Demarest T.G., Babbar M., Okur M.N., Dan X., Croteau D.L., Fakouri N.B.et al. . (2019) NAD+ metabolism in ageing and cancer. Ann. Rev. Cancer Biol. 3, 105&#x2013;130 10.1146/annurev-cancerbio-030518-055905</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cancerbio-030518-055905</ArticleId></ArticleIdList></Reference><Reference><Citation>Heske C.M. (2020) Beyond energy metabolism: exploiting the additional roles of NAMPT for cancer therapy. Front. Oncol. 9, 1514 10.3389/fonc.2019.01514</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2019.01514</ArticleId><ArticleId IdType="pmc">PMC6978772</ArticleId><ArticleId IdType="pubmed">32010616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy B.E., Sharif T., Martell E., Dai C., Kim Y., Lee P.W.K.et al. . (2016) NAD+ salvage pathway in cancer metabolism and therapy. Pharmacol. Res. 114, 274&#x2013;283 10.1016/j.phrs.2016.10.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2016.10.027</ArticleId><ArticleId IdType="pubmed">27816507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonker P. and Dedon P.C. (2011) Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int. J. Cancer 128, 1999&#x2013;2009 10.1002/ijc.25815</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.25815</ArticleId><ArticleId IdType="pmc">PMC3334345</ArticleId><ArticleId IdType="pubmed">21387284</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulua A.C., Simon A., Maddipati R., Pelletier M., Park H., Kim K.-Y.et al. . (2011) Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1- associated periodic syndrome (TRAPS). J. Exp. Med. 208, 519&#x2013;533 10.1084/jem.20102049</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20102049</ArticleId><ArticleId IdType="pmc">PMC3058571</ArticleId><ArticleId IdType="pubmed">21282379</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Su X., Quinn W.J. III, Hui S., Krukenberg K., Frederick D.W.et al. . (2018) Quantitative analysis of NAD synthesis-breakdown fluxes. Cell Metab. 27, 1067&#x2013;1080 10.1016/j.cmet.2018.03.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.03.018</ArticleId><ArticleId IdType="pmc">PMC5932087</ArticleId><ArticleId IdType="pubmed">29685734</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron A.M., Castoldi A., Sanin D.E., Flachsmann L.J., Field C.S., Puleston D.J.et al. . (2019) Inflammatory macrophage dependence on NAD+ salvage is a consequence of reactive oxygen species-mediated DNA damage. Nat. Immunol. 20, 420&#x2013;432 10.1038/s41590-019-0336-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0336-y</ArticleId><ArticleId IdType="pubmed">30858618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hageman G.J., Larik I., Pennings H.J., Haenen G.R., Wooter E.F. and Bast A. (2003) Systemic poly (ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. Free Radic. Biol. Med. 35, 140&#x2013;148 10.1016/S0891-5849(03)00237-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(03)00237-5</ArticleId><ArticleId IdType="pubmed">12853070</ArticleId></ArticleIdList></Reference><Reference><Citation>Tezcan G., Gurel C.B., Tutluoglu B., Onaran I. and Kanigur-Sultuybek G. (2009) The Ala allele at Val762Ala polymorphism in poly (ADP-ribose) polymerase-1 (PARP1) gene is associated with a decreased risk of asthma in a Turkish population. J. Asthma 46, 371&#x2013;374 10.1080/02770900902777791</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770900902777791</ArticleId><ArticleId IdType="pubmed">19484672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sethi G.S., Dharwal V. and Naura A.S. (2017) Poly (ADP-ribose)polymerase-1 in lung inflammatory disorders: a review. Front. Immunol. 8, 1172 10.3389/fimmu.2017.01172</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01172</ArticleId><ArticleId IdType="pmc">PMC5610677</ArticleId><ArticleId IdType="pubmed">28974953</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharwal V. and Naura A.S. (2018) PARP-1 inhibition ameliorates elastase induced lung inflammation and emphysema in mice. Biochem. Pharmacol. 150, 24&#x2013;34 10.1016/j.bcp.2018.01.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2018.01.027</ArticleId><ArticleId IdType="pubmed">29355504</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta R., Naura A.S., Zerfaoui M., Errami Y., Oumouna M., Kim K.et al. . (2011) PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model. Allergy 66, 853&#x2013;861 10.1111/j.1398-9995.2011.02549.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2011.02549.x</ArticleId><ArticleId IdType="pmc">PMC3150522</ArticleId><ArticleId IdType="pubmed">21276008</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Agnillo F., Walters K.-A., Xiao Y., Sheng Z.-M., Scherler K., Park J.et al. . (2021) Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci. Transl. Med. 13, eabj7790 10.1126/scitranslmed.abj7790</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj7790</ArticleId><ArticleId IdType="pmc">PMC11000440</ArticleId><ArticleId IdType="pubmed">34648357</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Wang J., Wang L., Aliyari S. and Cheng G. (2022) SARS-CoV-2 virus NSP14 impairs NRF2/HMOX1 activation by targeting sirtuin 1. Cell Molec. Immunol 19, 872&#x2013;882</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9217730</ArticleId><ArticleId IdType="pubmed">35732914</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A.-B. (1977) The effects of Acetate, metal cations, phenobarbitone, porphyrogens and substrates of glycine acyltransferase on the utilization of haem by rat liver apo-(tryptophan pyrrolase). Biochem. J. 164, 431&#x2013;438 10.1042/bj1640431</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj1640431</ArticleId><ArticleId IdType="pmc">PMC1164809</ArticleId><ArticleId IdType="pubmed">880248</ArticleId></ArticleIdList></Reference><Reference><Citation>Manetti M., Rosa I., Fioretto B.S., Matucci-Cerinic M. and Romano E. (2022) Decreased serum levels of SIRT1 and SIRT3 correlate with severity of skin and lung fibrosis and peripheral microvasculopathy in systemic sclerosis. J. Clin. Med. 11, 1362 10.3390/jcm11051362</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11051362</ArticleId><ArticleId IdType="pmc">PMC8910971</ArticleId><ArticleId IdType="pubmed">35268452</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerro J.I., Barrag&#xe1;n L.A., Mart&#xed;ne J.D., Montoya J.P., Pe&#xf1;a A., Sobrino F.E.et al. . (2021) Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infect. Dis. 21, 515 10.1186/s12879-021-06185-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06185-6</ArticleId><ArticleId IdType="pmc">PMC8170436</ArticleId><ArticleId IdType="pubmed">34078305</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsche M., Reichel D., Fellbrich A., Lixenfeld A.S., Rahm&#xf6;ller J., Vollstedt -J.et al. . (2021) Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19. Neurol. Res. Pract. 3, 34 10.1186/s42466-021-00135-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-021-00135-y</ArticleId><ArticleId IdType="pmc">PMC8214919</ArticleId><ArticleId IdType="pubmed">34148546</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees C.A., Rostad C.A., Mantus G., Anderson E.J., Chahroudi A., Jaggi P.et al. . (2021) Altered amino acid profile in patients with SARS-CoV-2 infection. Proc. Natl. Acad. Sci. U.S.A. 118, e2101708118 10.1073/pnas.2101708118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2101708118</ArticleId><ArticleId IdType="pmc">PMC8237604</ArticleId><ArticleId IdType="pubmed">34088793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozturk A., Bayraktar N., Bayraktar M., Ibrahim B., Bozok T. and Ceylan M.R. (2022) Evaluation of amino acid profile in serum of patients with COVID-19 for providing a new treatment strategy. J. Med. Biochem. 41, 526&#x2013;533 10.5937/jomb0-37514</Citation><ArticleIdList><ArticleId IdType="doi">10.5937/jomb0-37514</ArticleId><ArticleId IdType="pmc">PMC9618340</ArticleId><ArticleId IdType="pubmed">36381071</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia M.A., Barreras P.V., Lewis A., Pinilla G., Sokoll L.J., Kickler T.et al. . (2021) Cerebrospinal fluid in COVID-19 neurological complications: neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm. J. Neurological Sci. 427, 117517 10.1016/j.jns.2021.117517</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117517</ArticleId><ArticleId IdType="pmc">PMC8166041</ArticleId><ArticleId IdType="pubmed">34090021</ArticleId></ArticleIdList></Reference><Reference><Citation>Eden A., Kanberg N., Gostner J., Fuchs D., Hagberg L., Andersson L.-M.et al. . (2021) CSF biomarkers in patients with COVID-19 and neurologic symptoms: A Case Series. Neurology 96, e294&#x2013;e300</Citation><ArticleIdList><ArticleId IdType="pubmed">33004602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitt T.M. and Spector R. (1987) Transport of quinolinic acid into rabbit and rat brain. Neurochem. Res. 12, 625&#x2013;628 10.1007/BF00971011</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00971011</ArticleId><ArticleId IdType="pubmed">2956529</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui S., Schwarcz R., Rapoport S.I., Takada Y. and Smith Q.R. (1991) Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J. Neurochem. 56, 2007&#x2013;2017 10.1111/j.1471-4159.1991.tb03460.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1991.tb03460.x</ArticleId><ArticleId IdType="pubmed">1827495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair L.V., Neyens D., Ramsay G., Taylor P.M. and Cantrell D.A. (2018) Single cell analysis of kynurenine and system L amino acid transport in T cells. Nature Commun. 9, 1981 10.1038/s41467-018-04366-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04366-7</ArticleId><ArticleId IdType="pmc">PMC5958064</ArticleId><ArticleId IdType="pubmed">29773791</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyes M.P., Saito K., Crowley J.S., Davis L.E., Demitrack M.A., Der M.et al. . (1992) Quinolinic and and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115, 1249&#x2013;1273 10.1093/brain/115.5.1249</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/115.5.1249</ArticleId><ArticleId IdType="pubmed">1422788</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyes M.P. and Morrison P.F. (1997) Quantification of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues. J. Neurochem. 68, 280&#x2013;288 10.1046/j.1471-4159.1997.68010280.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.68010280.x</ArticleId><ArticleId IdType="pubmed">8978736</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N., Di Napoli M., Biller J., Siegler J.E., Shekhar R., McCullough D.et al. . (2021) The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr. Neurol. Neurosci. Rep. 21, 44 10.1007/s11910-021-01130-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D. and VanElzakker M.B. (2021) Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 12, 698169 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B., Head R., Pringle K.G., Lumbers E.R. and Martin J.H. (2022) &#x201c;LONG COVID&#x201d;-A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol. Res. Perspect. 10, e00911 10.1002/prp2.911</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X., Li W., Wang T., Ran D., Davalos V., Planas-Serra L.et al. . (2022) Accelerated biological aging in COVID-19 patients. Nat. Commun. 13, 2135 10.1038/s41467-022-29801-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29801-8</ArticleId><ArticleId IdType="pmc">PMC9018863</ArticleId><ArticleId IdType="pubmed">35440567</ArticleId></ArticleIdList></Reference><Reference><Citation>Cysique L.A., Jakabek D., Bracken S.G., Allen-Davidian Y., Heng B., Chow S.et al. . (2023) The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC. Ann. Cln. Transl. Neurol. 2023, 1&#x2013;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10424655</ArticleId><ArticleId IdType="pubmed">37318955</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A.F., Supasitthumrong T., Tunvirachaisakul C., Abo Algon A.A., Al-Hakeim H.K. and Maes M. (2022) The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis. BMC Infectious Dis. 22, 615 10.1186/s12879-022-07582-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07582-1</ArticleId><ArticleId IdType="pmc">PMC9284970</ArticleId><ArticleId IdType="pubmed">35840908</ArticleId></ArticleIdList></Reference><Reference><Citation>Nematollahi A., Sun G., Jayawickrama G.S. and Church W.B. (2016) Kynurenine aminotransferase isozyme inhibitors: a review. Int. J. Molec. Sci. 17, 946 10.3390/ijms17060946</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17060946</ArticleId><ArticleId IdType="pmc">PMC4926479</ArticleId><ArticleId IdType="pubmed">27314340</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida Y., Fujigaki H., Kato K., Yamazaki K., Yamazaki K., Fujigaki S.et al. . (2019) Selective and competitive inhibition of kynurenine aminotransferase 2 by glycyrrhizic acid and its analogues. Sci. Rep. 9, 10243 10.1038/s41598-019-46666-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46666-y</ArticleId><ArticleId IdType="pmc">PMC6629613</ArticleId><ArticleId IdType="pubmed">31308447</ArticleId></ArticleIdList></Reference><Reference><Citation>Narasimhan S., Zulick E.S., Novikov O., Parks A.J., Schlezinger J.J., Wang Z.et al. . (2018) Towards resolving the pro- and anti-Tumor effects of the aryl hydrocarbon receptor. Int. J. Molec. Sci. 19, 1388 10.3390/ijms19051388</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051388</ArticleId><ArticleId IdType="pmc">PMC5983651</ArticleId><ArticleId IdType="pubmed">29735912</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Trial: a first-in-humans dose finding study for an aryl hydrocarbon receptor inhibitor (AhRi) in patients with advanced cancer. Clinical Trials.gov. Identifier: NCT04069026 ClinicalTrials.gov API 28 August 2019</Citation></Reference><Reference><Citation>Rose M., Burgess J.T., O'Byrne K., Richard D.J. and Bolderson E. (2020) PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance. Front. Cell Dev. Biol. 8, 564601 10.3389/fcell.2020.564601</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.564601</ArticleId><ArticleId IdType="pmc">PMC7509090</ArticleId><ArticleId IdType="pubmed">33015058</ArticleId></ArticleIdList></Reference><Reference><Citation>Trammell S.A.J., Schmidt M.S., Weidemann B.J., Redpath P., Jaksch F., Dellinger R.W.et al. . (2016) Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 10.1038/ncomms12948</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12948</ArticleId><ArticleId IdType="pmc">PMC5062546</ArticleId><ArticleId IdType="pubmed">27721479</ArticleId></ArticleIdList></Reference><Reference><Citation>Elhassan Y.S., Kluckova K., Fletcher R.S., Schmidt M.S., Garten A., Doig C.L.et al. . (2019) Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces tanscriptomic and anti-inflammatory signatures. Cell Rep. 28, 1717&#x2013;1728 10.1016/j.celrep.2019.07.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.07.043</ArticleId><ArticleId IdType="pmc">PMC6702140</ArticleId><ArticleId IdType="pubmed">31412242</ArticleId></ArticleIdList></Reference><Reference><Citation>Altay O., Arif M., Li X., Yang H., Aydin M., Alkurt G.et al. . (2021) Combined metabolic activators accelerates recovery in mild-to-moderate COVID-19. Adv. Sci. 8, 1&#x2013;16 10.1002/advs.202101222</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.202101222</ArticleId><ArticleId IdType="pmc">PMC8420376</ArticleId><ArticleId IdType="pubmed">34180141</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahtinen S., Tong A.-J., Himmels P., Oh J., Paler-Martinez A., Km L.et al. . (2022) IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nat. Immunol. 23, 532&#x2013;542 10.1038/s41590-022-01160-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01160-y</ArticleId><ArticleId IdType="pubmed">35332327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski S.R., S&#xf8;gaard O.S., Tolstrup M., Straeke N.B., Lundgren J., &#xd8;stergaard L.et al. . (2021) Inflammation and platelet activation after COVID-19 vaccines-possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis. Front. Immunol 12, 779453 10.3389/fimmu.2021.779453</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.779453</ArticleId><ArticleId IdType="pmc">PMC8649717</ArticleId><ArticleId IdType="pubmed">34887867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadarangani M., Marchant A. and Kollmann T.R. (2021) Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat. Rev. Immunol. 21, 475&#x2013;484 10.1038/s41577-021-00578-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00578-z</ArticleId><ArticleId IdType="pmc">PMC8246128</ArticleId><ArticleId IdType="pubmed">34211186</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>